반응 #51541
ord-df69efdc1db442458306952e98924054
반응 방정식
반응물
시약
반응 조건
후처리
- 1workup.WAITwith warning to ambient temperature for several hours
- 2기타quenched with sat'd ammonium chloride
- 3추출Extracted with ethyl acetate
- 4세척washed organics with brine
- 5건조dried (MgSO4)
- 6농축concentrated
- 7기타The residue was purified by prep HPLC (
- 8세척C18 reverse phase column, elution with a H2O/CH3CN gradient with 0.5% TFA)
- 9workup.ADDITIONFractions containing desired compound
- 10추출extracted with ethyl acetate
- 11건조dried (MgSO4)
- 12농축concentrated
실험 절차
To a solution of 2-[(7bR,11aS)-1,2,7b,8,9,10,11,11a-octahydro-4H-pyrido[4,3-b)[1,4]thiazepino[6,5,4-hi]indol-6-yl]-5-methoxybenzaldehyde, the free base of EXAMPLE 16 (0.03 g, 0.08 mmol), in 5 mL of tetrahydrofuran at 0° C. was added methyl magnesium bromide (0.52 mL of a 3M solution in THF, 1.58 mmol). Stirred with warning to ambient temperature for several hours and then quenched with sat'd ammonium chloride. Extracted with ethyl acetate, washed organics with brine, dried (MgSO4) and concentrated. The residue was purified by prep HPLC (C18 reverse phase column, elution with a H2O/CH3CN gradient with 0.5% TFA). Fractions containing desired compound were then immediately free based with 1 N sodium hydroxide, extracted with ethyl acetate, dried (MgSO4) and concentrated to afford the title compound of EXAMPLE 21. LRMS (ES+): 397.1 (M+H)+.